Is Novavax (NVAX) A Potential Opportunity After Recent Share Price Weakness [Yahoo! Finance]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Yahoo! Finance
Wondering whether Novavax at about US$7.98 is a bargain or a value trap? This article walks through the key signals that matter for you. The stock has had a mixed run, with a 2.0% decline over the last week and a 20.0% decline over the last month. It still shows returns of 11.9% year to date and 26.5% over the past year, set against an 11.7% annualised decline over three years and a 95.9% drop over five years. Recent attention on Novavax has been shaped by ongoing interest in vaccine players and how they fit into broader healthcare themes. This helps explain why the share price has seen sharp moves over different time frames. For long term holders, the contrast between the one year gain and the much weaker multi year record is an important part of the story. Right now, Novavax has a valuation score of 5 out of 6 . The next sections will unpack what that means using different valuation approaches, before finishing with a way to pull all these signals together into a clearer pict
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- Shah Capital intends to vote against Novavax's board nominees, executive compensation [Yahoo! Finance]Yahoo! Finance
- 2 Growth Stocks Set to Flourishand 1 We Question [Yahoo! Finance]Yahoo! Finance
- New Novavax R&D Leader Raises Questions On Valuation Gap And Outlook [Yahoo! Finance]Yahoo! Finance
- 3 Companies Built Their Fortunes on COVID Vaccines, but Only 1 Has a Real Plan for What Comes Next [Yahoo! Finance]Yahoo! Finance
- Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development [Yahoo! Finance]Yahoo! Finance
NVAX
Earnings
- 2/26/26 - Beat
NVAX
Sec Filings
- 4/8/26 - Form SCHEDULE
- 3/27/26 - Form SCHEDULE
- 3/12/26 - Form 4
- NVAX's page on the SEC website